Call (407) 512-8878 Home About Dr. Chantasi

Services

Pain Care Regenerative Pain Management Back & Neck Pain Joint Pain Tendon & Ligament Neuropathy Stem Cell Therapy Cost Regenerative Medicine Guide Hormone Therapy Weight Loss Botox & Neurotoxins Korean Beauty Orlando Korean Skin Care Concierge Services Memberships Join PrimeCellMed

More

Payment Plans Patient Blog Industry Insights PrimeCell Shop FAQ Request a Consultation
← Patient Blog

Patient Blog

How to Compare Orlando Regenerative Clinics

Physician reviewing a patient intake and evaluation checklist before a regenerative medicine procedure

Orlando has a growing number of clinics offering regenerative and orthobiologic services. They are not interchangeable.

The clinics worth considering share a specific pattern:

  • A physician-level evaluation
  • Transparency about what product is actually being used and its regulatory status
  • Image-guided procedures where appropriate
  • An honest conversation about alternatives
  • A real follow-up plan

Clinics that skip one or more of these steps are the ones patients later regret choosing.

What This Means

If you're comparing providers, you're not just comparing price or marketing. You're comparing:

  • How carefully each clinic evaluates you
  • Who actually performs the procedure
  • Whether imaging guides it
  • Whether they'll disclose exactly what product they use and where it comes from
  • Whether they mention options beyond their own service line
  • What happens after you leave

Those six questions separate a careful practice from a rushed one better than anything on a clinic's website.

Candidacy

Not everyone who is curious about regenerative or orthobiologic options is a reasonable candidate for them. A good evaluation usually starts by ruling that out rather than assuming it in.

Musculoskeletal complaints, such as joint, tendon, or ligament pain that hasn't resolved with more conservative care, are the most common reason patients look into these services.

Typical reasons a clinician would advise against proceeding include:

  • Active infection
  • Certain cancers
  • Uncontrolled bleeding disorders
  • Pregnancy

A clinic that is willing to say "you're probably not a good fit for this" is behaving the way a medical practice should. One that never disqualifies anyone is worth a second look.

Clinical Evaluation

Two of the six criteria above show up most clearly at this stage.

The person doing your intake evaluation should be a licensed physician, an MD or DO. Ideally, they are board-certified in a field relevant to musculoskeletal or pain-related care, such as physical medicine and rehabilitation, sports medicine, orthopedics, or pain medicine.

That training is what lets a clinician separate, say, a knee that hurts from osteoarthritis versus a meniscus problem versus referred hip pain. These distinctions change what's clinically reasonable to recommend.

Ask directly who is evaluating you and what their board certification is. A clinic that can't answer specifically is a red flag.

The second is imaging guidance. For joint and soft-tissue injections, ultrasound lets the clinician visualize the target structure and confirm placement in real time, rather than relying on surface landmarks alone.

A 2024 umbrella review of 17 prior systematic reviews found ultrasound-guided injections were consistently more accurate than landmark-guided ("blind") injections across multiple joints (Shen et al., 2024).

Ask whether your specific procedure will be image-guided, and if not, why.

Available Options

A separate question is who performs the procedure once it's recommended.

In Florida, physicians may delegate certain tasks to physician assistants or nurse practitioners.

That delegation is supposed to be a deliberate clinical judgment: the supervising physician weighs the complexity and risk of the specific task and confirms the person performing it is properly trained, rather than delegating as a matter of routine (Fla. Admin.

Code Ann. R. 64B8-30.012, n.d.).

Some clinics have a physician perform every procedure. Others rely on mid-level staff or, in less careful settings, unsupervised medical assistants or aestheticians. Ask specifically who will do the procedure, not just who you met during your consultation.

A clinic worth its reputation will also walk you through options beyond its own service line: physical therapy, activity modification, bracing, medication management, or referral to a surgeon, depending on what your evaluation shows.

The International Society for Stem Cell Research's patient guide recommends asking providers whether they've discussed established, conventional options alongside anything investigational (International Society for Stem Cell Research [ISSCR], 2024).

A clinic that only ever recommends the service it sells is offering a narrower conversation than a genuine evaluation should.

Benefits, Limitations & Risks

Product Transparency

Product transparency is where a lot of regenerative-medicine marketing breaks down. Ask what product will be used, who manufactures or processes it, and its regulatory status.

Is it FDA-cleared or approved for the specific use being discussed? Is it part of a registered clinical trial, or a compounded or minimally processed product that hasn't gone through that review?

The FDA has stated plainly that, outside a small number of approved cord-blood-derived products, most stem cell and exosome products marketed directly to consumers have not received FDA approval for orthopedic conditions such as osteoarthritis, tendon irritation, or joint, back, or neck pain.

Patients charged for such products outside a clinical trial should regard that as a warning sign, not a selling point (U.S. Food and Drug Administration [FDA], 2020, 2021).

A clinic that won't answer sourcing and regulatory-status questions directly is one of the clearest red flags in this process.

Limitations

The limitations run in both directions. Even properly sourced, appropriately used orthobiologic products carry real limits: results vary by patient, and the research base is still developing for many musculoskeletal applications. A careful clinic says so rather than promising a specific outcome.

What the Evidence Shows

Current evidence supports image guidance improving injection accuracy (Shen et al., 2024). It also confirms a large, loosely regulated direct-to-consumer market for unproven stem cell products, with Florida among the states with the highest concentration of such clinics (Turner & Knoepfler, 2016).

What the evidence does not yet establish, for most orthobiologic applications outside FDA-approved indications, is a guaranteed outcome for any specific condition.

That gap between "plausible and being studied" and "established for this condition" is exactly why source transparency and a clinician willing to name that gap both matter.

Recovery / Next Steps

Whatever procedure you choose, ask what follow-up looks like before you schedule anything. Is there a scheduled recheck? A way to reach the clinic with questions afterward? A plan for reassessing if your symptoms haven't changed the way you expected?

A clinic with no follow-up plan at all, where you have the procedure and are on your own afterward, is a red flag regardless of how the initial consultation went.

Ongoing monitoring is part of how a clinician knows whether a given approach is actually working for you.

Orlando Considerations

Florida's large, cash-pay wellness and aesthetics market has made Orlando a common destination for regenerative-medicine marketing. That volume is part of why comparison shopping here benefits from a checklist, rather than a gut reaction to a clinic's website or advertising.

The same six criteria apply regardless of neighborhood or price point.

Frequently Asked Questions

Is a stem cell clinic in Orlando FDA-approved?

Ask that question of any specific clinic directly, since the answer depends on the exact product being used. As a general matter, most stem cell and exosome products marketed directly to consumers have not received FDA approval for orthopedic use (FDA, 2020).

Do I need a referral to be evaluated by a regenerative medicine clinic?

Typically no — most Orlando practices offering these services accept self-referred patients for an initial evaluation, though your primary care physician’s records and imaging are useful to bring along.

Is ultrasound guidance always necessary for an injection?

Not for every procedure, but for most joint and soft-tissue injections it improves placement accuracy compared with a landmark-guided approach (Shen et al., 2024). Ask whether your specific procedure will use it.

Can a medical assistant legally perform a regenerative injection in Florida?

Delegation rules in Florida require the supervising physician to make a specific judgment about the complexity of the task and the training of the person performing it — it isn’t something a clinic can delegate as a blanket policy (Fla. Admin.

Code Ann. R. 64B8-30.012, n.d.). Ask directly who will perform your procedure.

What if a clinic won’t tell me where its product comes from?

Regard that as a stopping point in the conversation, not a detail to let go. Legitimate practices can answer sourcing and regulatory-status questions specifically.

Most regenerative and orthobiologic services discussed elsewhere on this site are offered outside FDA-approved clinical trials and are investigational — they are not FDA-approved for those uses.

This article is general education, not medical advice. Individual results vary. Any decision about candidacy or procedure choice should be made with a licensed physician after a direct evaluation.

Medically reviewed by Kenny Chantasi, DO.

References

Florida Board of Medicine. (n.d.). Physician assistant performance (Fla. Admin. Code Ann. R. 64B8-30.012). https://www.law.cornell.edu/regulations/florida/Fla-Admin-Code-Ann-R-64B8-30-012

International Society for Stem Cell Research. (2024). The ISSCR guide to stem cell treatments (Version 12).

Shen, P.-C., Lin, T.-Y., Wu, W.-T., Özçakar, L., & Chang, K.-V. (2024). Comparison of ultrasound- versus landmark-guided injections for musculoskeletal pain: An umbrella review. Journal of Rehabilitation Medicine, 56, jrm40679. https://doi.org/10.2340/jrm.v56.40769

Turner, L., & Knoepfler, P. (2016). Selling stem cells in the USA: Assessing the direct-to-consumer industry. Cell Stem Cell, 19(2), 154–157. https://doi.org/10.1016/j.stem.2016.06.007

U.S. Food and Drug Administration. (2020, July 22). Consumer alert on regenerative medicine products including stem cells and exosomes.

U.S. Food and Drug Administration. (2021, June 3). Important patient and consumer information about regenerative medicine therapies.

Last medically reviewed: August 24, 2026.

Ready when you are

Talk with a physician about your options

Have questions about whether this is right for you? Book a consultation with Dr. Chantasi, or call the clinic and we'll talk it through.

Orlando, FL · Mon–Fri 10am–6pm